Co-Authors
This is a "connection" page, showing publications co-authored by Antonella Cingolani and Massimo Fantoni.
Connection Strength
0.740
-
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab. Infection. 2020 Oct; 48(5):767-771.
Score: 0.223
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
Score: 0.060
-
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021 06 18; 6(13).
Score: 0.059
-
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital. Intern Emerg Med. 2022 01; 17(1):53-64.
Score: 0.059
-
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
Score: 0.058
-
Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
Score: 0.057
-
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy. PLoS One. 2020; 15(9):e0238414.
Score: 0.056
-
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br J Haematol. 2020 10; 191(2):207-211.
Score: 0.056
-
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
Score: 0.056
-
Comparative analysis of synovial inflammation after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Jul 06.
Score: 0.056